O slideshow foi denunciado.
Seu SlideShare está sendo baixado. ×

EPIDEMEOLOGY OF TYPHOID FEVER.pdf

Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Anúncio
Próximos SlideShares
Typhoid fever
Typhoid fever
Carregando em…3
×

Confira estes a seguir

1 de 28 Anúncio

Mais Conteúdo rRelacionado

Semelhante a EPIDEMEOLOGY OF TYPHOID FEVER.pdf (20)

Mais de PriyankaSharma89719 (20)

Anúncio

Mais recentes (20)

EPIDEMEOLOGY OF TYPHOID FEVER.pdf

  1. 1. EPIDEMEOLOGY OF TYPHOID FEVER SANNIPATAJ JAWAR PRESENTED BY AYUSHI TAYAL (BATCH -2019)
  2. 2. CONTENTS INTRODUCTION PROBLEM STATEMENT EPIDEMEOLOGICAL DETERMINANTS CLINICAL FEATURES LABORATORY DIAGNOSIS OF TYPHOID CONTROL OF TYPHOID FEVER AYURVEDIC CONCEPT OF TYPHOID FEVER
  3. 3. WHAT IS TYPHOID FEVER? • TYPHOID FEVER IS A BACTERIAL INFECTION THAT CAN SPREAD THROUGHOUT THE BODY, AFFECTING MANY ORGANS. • RESULT OF SYSTEMIC INFECTION CAUSED BY SALMONELLA TYPHI. • CLINICALLY CHARACTERIZED BY TYPICAL CONTINUOUS FEVER FOR 3 TO 4 WEEKS, RELATIVELY BRADYCARDIA WITH INVOLVEMENT OF INTESTINAL LYMPHOID TISSUES AND CONSIDERABLE CONSTITUTIONAL SYMPTOMS. • "ENTERIC FEVER" INCLUDES BOTH TYPHOID AND PARATYPHOID FEVER. MAY OCCUR SPORADICALLY, EPIDEMICALLY OR ENDEMICALLY. FOUND ONLY IN HUMAN.
  4. 4. PROBLEM STATEMENT GLOBAL DISEASE BURDEN IS 21 MILLION CASES ANNUALLY, (2,10,00,000 CASES). WITH DEATHS OF 2,16,000-6,00,000 PER YEAR. MAJORITY OF THIS BURDEN OCCURS IN ASIA. INDIA: TYPHOID FEVER IS ENDEMIC IN INDIA. DATA SHOWS 1.53 MILLION CASES & 361 DEATHS IN 2013. WORLD’S LARGEST OUTBREAK OF TYPHOID IN SANGLI ON DEC 1975 TO FEB 1976
  5. 5. EPIDEMIOLOGICAL DETERMINANTS • 1. AGENT FACTORS • 2. HOST FACTORS • 3. ENVIRONMENTAL & SOCIAL FACTORS • 4. INCUBATION PERIOD • 5. MODE OF TRANSMISSION
  6. 6. 1 TYPHOID FEVER MAINLY CAUSED BY THE BACTERIUM SALMONELLA TYPHI FROM THE FAMILY ENTEROBACTERIACEAE. 2 S. TYPHI IS A GRAM-NEGATIVE, FACULTATIVE AEROBIC, NON SPORE FORMING BACTERIA THAT ISMOTILE DUE TO ITS PERITRICHOUS FLAGELLA. 3 THE BACTERIA GROWS BEST AT 37 C. AGENT FACTORS -
  7. 7. B- RESERVOIR OF INFECTION HUMAN IS THE ONLY RESERVOIR 1 CASE • - A CASE IS INFECTIOUS AS LONG AS BACILLI APPEARS IN STOOLS OR URINE. • CASE MAY BE MISSED, MILD OR SEVERE. • 2. CARRIERS • TEMPORARY/INCUBATORY EXCRETE BACILLI FOR 6 TO 8 WEEKS. CLINICAL SYMPTOMS ARE NOT SHOWN IN PERSON ,BUT THEY ARE CAPABLE OF TRANSMITTING THE INFECTION • CHRONIC CARRIER -EXCRETE BACILLI FOR MORE THAN A YEAR, ORGANISM PERSIST IN GALL BLADDER/BILIARY TRACT. . E.G. "TYPHOID MARRY" REAL NAME MARY MALLON •
  8. 8. TYPHOID MARY • MARY MALLON WAS A COOK IN OYSTER BAY, NEW YORK IN EARLY 1900 S • AS A HEALTHY CARRIER OF SALMONELLA TYPHI HER NICKNAME OF “TYPHOID MARY” HAD BECOME SYNONYMOUS WITH THE SPREAD OF DISEASE, AS MANY WERE INFECTED DUE TO HER DENIAL OF BEING ILL • A COMBINATION OF PEACH ICE CREAM AND MALLON'S POOR HAND WASHING LIKELY SPARKED TYPHOID FEVER OUTBREAKS • GAVE RISE TO MORE THAN 1300 CASES IN HER LIFE TIME. • SHE DIED OF PNEUMONIA AFTER 26 YEARS IN QUARANTINE
  9. 9. C SOURCE OF INFECTION PRIMARY SOURCES • FAECES & URINE OF CASES AND CARRIERS. • FAECAL CARRIERS ARE MORE FREQUENT THAN URINARY CARRIERS SECONDARY SOURCES CONTAMINATED - WATER - FOOD - FINGERS - FLIES
  10. 10. • HOW DOES THE BACTERIA CAUSE DISEASE ? • INGESTION OF CONTAMINATED FOOD OR WATER SALMONELLA BACTERIA • INVADE SMALL INTESTINE AND ENTER THE BLOODSTREAM • CARRIED BY WHITE BLOOD CELLS IN THE LIVER, SPLEEN, AND BONE MARROW • MULTIPLY AND RE - ENTER THE BLOODSTREAM • BACTERIA INVADE THE GALLBLADDER, BILIARY SYSTEM, AND THE LYMPHATIC TISSUE OF THE BOWEL AND MULTIPLY IN HIGH NUMBERS • THEN PASS INTO THE INTESTINAL TRACT AND CAN BE IDENTIFIED FOR DIAGNOSIS IN CULTURES FROM THE STOOL TESTED IN THE LABORATORY
  11. 11. 2- HOST FACTORS • (A) AGE- OCCUR AT ANY AGE BUT HIGHEST INCIDENCE IN 5-19 YRS. AGE GROUP. • (B) SEX- CASES MORE IN MALES THAN FEMALE - CARRIER RATE IS MORE IN FEMALES • (C) IMMUNITY- ANTIBODY MAY BE STIMULATED BY INFECTION OR IMMUNIZATION. ANTIBODY AGAINST (O) ANTIGEN IS HIGHER IN PATIENT WITH THE DISEASE AND ANTIBODY AGAINST (H) ANTIGEN IS HIGHER IN IMMUNIZED PERSON. S.TYPHI IS INTRACELLULAR ORGANISM SO CELL MEDIATED IMMUNITY PLAYS A MAJOR ROLE IN COMBATING THE INFECTION.
  12. 12. 3- ENVIRONMENTAL & SOCIAL FACTORS TYPHOID FEVER REGARDED AS "INDEX OF GENERAL SANITATION" IN ANY COUNTRY. • INCREASE INCIDENCE IN JULY-SEPTEMBER. • OUTSIDE HUMAN BODY BACILLI FOUND IN ICE & ICE CREAM- OVER A MONTH WATER-2 TO 7 DAYS BUT NOT MULTIPLY SOIL IRRIGATED WITH SEWAGE- 35 TO 70 DAYS FOOD- MULTIPLY & SURVIVE FOR SOMETIME MILK- GROW RAPIDLY WITHOUT ALTERING ITS TASTE VEGETABLES GROW IN SEWAGE PLANT. • POLLUTION OF DRINKING WATER SUPPLIES. • OPEN AREA DEFECATION & URINATION. • LOW PERSONAL HYGIENE. • HEALTH IGNORANCE.
  13. 13. INCUBATION PERIOD • INCUBATION PERIOD – USUALLY 10-14 DAYS BUT IT MAY BE AS SHORT AS 3 DAYS OR AS LONG AS 21 DAYS DEPENDING UPON THE DOSE OF BACILLI INGESTED.
  14. 14. SIGNS AND SYMPTOMS • CLASSICALLY, THE COURSE OF UNTREATED TYPHOID FEVER IS DIVIDED INTO FOUR DISTINCT STAGES, EACH LASTING ABOUT A WEEK. OVER THE COURSE OF THESE STAGES, THE PATIENT BECOMES EXHAUSTED. • CLINICAL FEATURES • INITIAL WEEKS OF THE INFECTION: IN THE FIRST WEEK: ⚫ FEVER IN STEP LADDER FASHION ⚫ RELATIVE BRADYCARDIA, MALAISE, ⚫ HEADACHE • COUGH, SORE THROAT. • A BLOODY NOSE (EPISTAXIS) IS SEEN IN A QUARTER OF CASES, AND ABDOMINAL PAIN IS ALSO POSSIBLE WITH CONSTIPATION OR PEA SOUP DIARRHOEA.
  15. 15. LATER STAGES OF INFECTION • SERIOUS COMPLICATIONS OCCUR IN UPTO 10% OF CASES, IF ILLNESS PROLONG BEYOND 2 WEEKS. • THIRD WEEK: INTESTINAL HAEMORRHAGE AND PERFORATION. • SIGNS OF SHOCK, SUDDEN DROP IN TEMPERATURE , DARK OR FRESH BLOOD IN STOOLS. • • RARE COMPLICATIONS: • URINE RETENTION, PNEUMONIA, MYOCARDITIS, CHOLECYSTITIS, NEPHRITIS.
  16. 16. LABORATORY DIAGNOSIS MICROBIOLOGICAL PROCEDURS SEROLOGICAL PROCEDURS NEW DIAGNOSTIC TESTS
  17. 17. SEROLOGICAL PROCEDURES FELIX-WIDAL TEST MEASURES AGGLUTINATING ANTIBODIES LEVELS AGAINST O & H ANTIGENS SERUM AGGLUTININS RAISE ABRUPTLY DURING THE 2ND OR 3RDWEEK
  18. 18. LIMITATIONS OF WIDAL TEST • TEST HAS MODERATE SENSITIVITY AND SPECIFICITY. • TEST CAN BE NEGATIVE IN 30% OF CULTURE PROVEN CASES. • THIS TEST GIVES FALSE POSITIVE RESULTS DUE TO OTHER CLINICAL CONDITIONS.
  19. 19. CONTROL OF TYPHOID FEVER 1. CONTROL OF: • RESERVOIRS • CASES • CARRIERS 2. CONTROL OF SANITATION 3. IMMUNIZATION • CONTROL OF RESERVOIRS • IDENTIFICATION, ISOLATION, TREATMENT & DISINFECTION. • CONTROL OF CASES: • EARLY DIAGNOSIS, NOTIFICATION, ISOLATION, TREATMENT, FOLLOW-UP. • CONTROL CARRIERS: • IDENTIFICATION, TREATMENT, SURGERY, SURVEILLANCE, HEALTH EDUCATION
  20. 20. CONTROL OF CASES AND CARRIERS • CONTROL OF CASES • EARLY DIAGNOSIS: BLOOD & STOOL CULTURES ARE IMP. IN DIAGNOSIS OF THE CASES. • NOTIFICATION: INFORM THE OFFICIALS. • ISOLATION: SEPARATE THE PATIENTS TO PREVENT SPREAD OF INFECTION. • TREATMENT: DRUG OF CHOICE: FLUOROQUINOLONES. • FOLLOW-UP: EXAMINATION OF STOOLS & URINE FOR 3-4 MONTHS AFTER DISCHARGE. • CONTROL OF CARRIERS • IDENTIFICATION: TO PREVENT ULTIMATE SOURCE - TYPHOID. • TREATMENT: AMPICILLIN OR AMOXYCILLIN WITH PROBENECID FOR 6 WEEKS. • SURGERY: CHOLECYSTECTOMY, NEPHRECTOMY CAN BE DONE. • SURVEILLANCE: CARRIERS TO BE PREVENTED FROM FOOD HANDLING. • HEALTH EDUCATION: REGARDING HAND WASHING AND SANITATION , ABOUT PERSONAL HYGIENE.
  21. 21. CONTROL OF SANITATION • PROTECTION & PURIFICATION OF DRINKING WATER SUPPLIES. • IMPROVEMENT OF BASIC SANITATION. • PROMOTION OF FOOD HYGIENE. • SANITATION COMBINED WITH HEALTH EDUCATION RESULTS IN REDUCTION OF TYPHOID MORBIDITY
  22. 22. IMMUNIZATION VACCINATION RECOMMENDED TO: • ANY PERSON ABOVE 2 YRS OF AGE • THOSE LIVE IN ENDEMIC AREA • HOUSEHOLD CONTACTS • GROUP AT RISK LIKE SCHOOL CHILDREN AND HOSPITAL STAFF ETC. • THOSE ATTENDING MELAS & YATRAS
  23. 23. THREE TYPES OF VACCINES 1 INJECTABLE TYPHOID VACCINE (TYPHIM -VI, TYPHIVAX) 2. THE LIVE ORAL VACCINE (TYPHORAL) 3. Cl as s i c al v ac c i ne FACTS OF VACCINES Fo r Ty p h o i d IMMUNITY LASTS FOR 3 YEARS NEED A BOOSTER after ever y vaccine.
  24. 24. TYPES OF VACCINES • INJECTABLE TYPHIM -VI VACCINE • 1. THIS SINGLE-DOSE INJECTABLE TYPHOID VACCINE, FROM THE BACTERIAL CAPSULE OF S. TYPHI STRAIN OF TY21A. • 2. THIS VACCINE IS RECOMMENDED FOR USE IN CHILDREN OVER 2 YEARS OF AGE. • 3. SUB-CUTANEOUS OR INTRAMUSCULAR INJECTION • 4. EFFICACY: 64% -72% • TYPHORAL VACCINE • 1. THIS IS A LIVE-ATTENUATED-BACTERIA VACCINE MANUFACTURED FROM THE TY21A STRAIN OF S. TYPHI. • 2. THE EFFICACY RATE RANGES FROM 50-80% • 3. NOT RECOMMENDED FOR USE IN CHILDREN YOUNGER THAN 6 YEARS OF AGE • 4. THE COURSE CONSISTS OF ONE CAPSULE ORALLY, TAKEN AN HOUR BEFORE FOOD WITH A GLASS OF WATER OR MILK (1STDAY, 3RD DAY & 5TH DAY) • 5. NO ANTIBIOTIC SHOULD BE TAKEN DURING THIS PERIOD
  25. 25. lassical vaccine t is a kille vaccine o mo e than six month baby ubcutaneously use i st ose at six months econ ose afte fou to six weeks
  26. 26. CORRELATION OF SANNIPATAJ SANTATA JWARA AND TYPHOID FEVER (IN ACCORDANCE WITH CHARAK CHIKITSA 3) • वर्तमान काल में टाईफड्ड (TYPHOID FEVER) का समय 3 सप्ताह का माना जार्ा है। सन्निपार् सन्तर् ज्वर को TYPHOID FEVER माना जा सकर्ा है। सन्निपार्ज ज्वर में दोष क े र्ारर्म्य से कफप्रधान, वार्प्रधान, न्नपत्तप्रधान ये ३ प्रकार होर्े हैं। कफ में 'अत्यर्त शीर्न्नपडका भृशमङ्ग े भ्य उन्नत्तष्ठन्तन्त यह बार् न्ननयानस्र्ान में बर्ाई गई है। कफ का वर्त श्वेर् होर्ा है। इसन्नलए ये न्नपन्नडकाएँ भी श्वेर् वर्त की होोंगी। टाईफाइड में श्वेर् वर्त की न्नपन्नडका न्ननकलर्ी है।

×